U.S. FDA approves Alexion Pharma's blood disorder drug

(Reuters) – The U.S. Food and Drug Administration has approved Alexion Pharmaceuticals Inc’s blood disorder drug Ultomiris, the pharma regulator’s website showed on Friday. The drug aims to treat paroxysmal nocturnal hemoglobinuria (PNH), a rare, acquired, life-threatening disorder in which red blood cells divide prematurely. Reporting by Manas Mishra in Bengaluru; Editing by Sriraj Kalluvila… Read More »

A Look Inside Sporteluxe’s Exclusive ‘Table for 12’ Dinner Series For 2018

If you visit Sporteluxe regularly (and we hope that you do!) you would’ve seen that in the last few months or so, we’ve rolled out an exclusive event series called Table for 12. Table for 12 is exactly what its name suggests; an intimate gathering aimed at bringing together inspiring, hard-working women who are killing… Read More »